It responded to the Strategic Industrial Sectors call for projects issued by the Investments for the Future Programme. Nearly €2 million in funding for the project over 5 years has been provided by Bpifrance.
MabDesign's challenge is to build an association that will lead the boom in the French industrial antibody sector. Involved in this project are health competitiveness clusters including Atlanpôle Biothérapie, Cancer-Bio-Santé, Eurobiomed, Medicen and Lyonbiopole, pharmaceutical companies including Laboratoires Pierre Fabre, LFB and Sanofi, biotech companies and a group of some 75 service provider SMEs.
The MabDesign project has two parts:
Structuring the French therapeutic antibody sector
Supporting SME growth and competitiveness
Nicolas GROUX - Chief Operating Officer at MabDesign
For more information visit : www.mabdesign.fr